TY - JOUR
T1 - Tumor microenvironment modulation via gold nanoparticles targeting malicious exosomes
T2 - Implications for cancer diagnostics and therapy
AU - Roma-Rodrigues, Catarina
AU - Raposo, Luís R.
AU - Cabral, Rita
AU - Paradinha, Fabiana
AU - Baptista, Pedro V.
AU - Fernandes, Alexandra R.
N1 - UCIBIO - FCT/MEC - UID/Multi/04378/2013 ;
ERDF - POCI-01-0145-FEDER-007728;
FCT/MEC - SFRH/BD/70202/2010
PY - 2017/1/14
Y1 - 2017/1/14
N2 - Exosomes are nanovesicles formed in the endosomal pathway with an important role in paracrine and autocrine cell communication. Exosomes secreted by cancer cells, malicious exosomes, have important roles in tumor microenvironment maturation and cancer progression. The knowledge of the role of exosomes in tumorigenesis prompted a new era in cancer diagnostics and therapy, taking advantage of the use of circulating exosomes as tumor biomarkers due to their stability in body fluids and targeting malignant exosomes’ release and/or uptake to inhibit or delay tumor development. In recent years, nanotechnology has paved the way for the development of a plethora of new diagnostic and therapeutic platforms, fostering theranostics. The unique physical and chemical properties of gold nanoparticles (AuNPs) make them suitable vehicles to pursuit this goal. AuNPs’ properties such as ease of synthesis with the desired shape and size, high surface:volume ratio, and the possibility of engineering their surface as desired, potentiate AuNPs’ role in nanotheranostics, allowing the use of the same formulation for exosome detection and restraining the effect of malicious exosomes in cancer progression.
AB - Exosomes are nanovesicles formed in the endosomal pathway with an important role in paracrine and autocrine cell communication. Exosomes secreted by cancer cells, malicious exosomes, have important roles in tumor microenvironment maturation and cancer progression. The knowledge of the role of exosomes in tumorigenesis prompted a new era in cancer diagnostics and therapy, taking advantage of the use of circulating exosomes as tumor biomarkers due to their stability in body fluids and targeting malignant exosomes’ release and/or uptake to inhibit or delay tumor development. In recent years, nanotechnology has paved the way for the development of a plethora of new diagnostic and therapeutic platforms, fostering theranostics. The unique physical and chemical properties of gold nanoparticles (AuNPs) make them suitable vehicles to pursuit this goal. AuNPs’ properties such as ease of synthesis with the desired shape and size, high surface:volume ratio, and the possibility of engineering their surface as desired, potentiate AuNPs’ role in nanotheranostics, allowing the use of the same formulation for exosome detection and restraining the effect of malicious exosomes in cancer progression.
KW - Cancer diagnostics
KW - Cancer therapy
KW - Exosomes
KW - Gold nanoparticles
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85009892134&partnerID=8YFLogxK
U2 - 10.3390/ijms18010162
DO - 10.3390/ijms18010162
M3 - Review article
AN - SCOPUS:85009892134
SN - 1661-6596
VL - 18
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 1
M1 - 162
ER -